Bacterial infections:
Indications for: REBYOTA
Prevention of recurrence of Clostridioides difficile infection (CDI) in adults following antibiotic treatment for recurrent CDI.
Limitations of Use:
Not for treatment of CDI.
Adult Dosage:
For rectal use only. Empty bladder and bowel before administration. Give a single dose (150mL) 24–72hrs after the last dose of antibiotics for CDI.
Children Dosage:
<18yrs: not established.
REBYOTA Warnings/Precautions:
Manufactured from human fecal matter. Risk of transmissible infectious agents. Potential presence of food allergens. Acute allergic reactions. Have appropriate medical treatment immediately available.
REBYOTA Interactions:
Avoid any oral antibiotic therapy for up to 8 weeks after Rebyota administration.
Adverse Reactions:
Abdominal pain, diarrhea, abdominal distention, flatulence, nausea.
Generic Drug Availability:
NO
How Supplied:
Single-dose cartons—6
